DNA Biomed Solns (DNA) — Free Cash Flow Generation Index

Latest as of December 2022: 1.00x

DNA Biomed Solns (DNA) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of ILA394.50K represents 1% of operating cash flow (ILA394.50K). See DNA working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

ILA394.50K

ILA

Operating Cash Flow

ILA394.50K

ILA

Capital Expenditures

ILA0.00

ILA

DNA Biomed Solns Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for DNA Biomed Solns across 1 annual periods. Explore DNA Biomed Solns (DNA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for DNA Biomed Solns (2024–2024)

Year-by-year Free Cash Flow Generation Index for DNA Biomed Solns. For the full company profile including market capitalisation, see DNA Biomed Solns market capitalisation.

Year	FCG Index	Free Cash Flow (ILA)	Operating CF	Capital Expenditures	YoY Change
2024	1.00x	ILA1.61 Million	ILA1.61 Million	ILA0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).